Sales 9% below us, but partly temporary; orders grew 61% Mixed outlook, reiterates guidance, but cites more uncertainty Cut '25e EBITA 7%, but leave '26e-'27e intact as order book +24% Sales weakness seems partly temporary Sales were weaker than we expected...

Orders +4%, sales -9%, adj. EBITA -22% vs. our estimates EBITA miss driven by 3 high-volume delivery delays, opex better Maintains guidance, more cost savings, strong orders offset miss Q1 results Orders were up 61% y-o-y and 4% above our estimate, marking...

Q1e sales flat q-o-q, slight margin improvement to 5.6% adj. EBITA '25e-'27e adj. EBITA down ~7% on FX and slightly slower cost cuts '25e adj. EBITA now in line with guidance; P/E 9-7x, peers 13-11x Q1 expectations For Q1 we expect sales in line with...

Surprisingly strong orders support view that cycle has bottomed Soft guidance, but we think company is being conservative Keep '25e adj. EBITA 11% above guidance, P/E 35% below peers Q4 results Sales were in line with our expectations, down 4% y-o-y ...

Orders +41%, sales +0%, adj. EBITA +12% vs. ABGSCe High NRIs lower quality of beat, but orders indicate cycle bottom '25e guidance a bit soft, but likely conservative, we are 13% above Q4 results Order intake came in at SEK 761m (+41% vs. ABGSCe 540m...

Q4e sales -4% y-o-y (-11% org.), adj. EBITA margin 4.6% (6.5%) Q4 to suffer from demand weakness, but orders to keep improving Demand to stabilise in H1, pick-up in H2, cost reductions effect in H1 Q4 expectations We make no significant changes to our...